Graphdiyne oxide nanosheets reprogram immunosuppressive macrophage for cancer immunotherapy

Mengyu Guo,Jing Liu,Xi Chen,Zhen You,Fene Gao,Tao Liu,Jiayu Ren,Jiaming Liu,Zecheng Xiong,Ying Liu,Yaling Wang,Huibiao Liu,Xueling Chang,Rong Cai,Chunying Chen
DOI: https://doi.org/10.1016/j.nantod.2022.101543
IF: 17.4
2022-08-01
Nano Today
Abstract:Graphdiyne oxide (GDYO) nanosheets have remarkable electronic, mechanical, and thermal properties, which is hoped to act a better alternative for biomedical applications. Tumor-associated macrophage (TAM) is a promising cell population for nanotechnology application to cancer immunotherapy. In the present study, we found M2-like macrophages can be polarized to kill cancer cells with GDYO treatment via activation of pro-inflammatory pathways and GDYO injected intraperitoneally reduced tumor growth in a melanoma-bearing mouse model. In addition, GDYO activated cytotoxic T cells either directly or indirectly via macrophages, enhancing checkpoint inhibitor response in a breast cancer model. We expect that GDYO has invoked both the innate and adaptive arms of the immune system that are likely to enhance efficacy of cancer immunotherapy.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry
What problem does this paper attempt to address?